Ipamorelin + CJC-1295

Ipamorelin Acetate + Modified GRF 1-29

AI explanation

Ipamorelin + CJC-1295 Explained

This peptide combination is basically a one-two punch that tells your body to produce more growth hormone. People use it because growth hormone naturally declines as you age, and this stack helps restore it for muscle building, faster recovery, fat loss, and generally feeling younger. Think of it like turning up the volume on a system your body already has.

Here's how it actually works: Your pituitary gland is like the control center that releases growth hormone, but it needs two different signals to do it properly. CJC-1295 is like sending a priming signal—it knocks on the door and gets the gland ready to release, while also extending how long that release window stays open. Ipamorelin comes in on a different pathway, binding to separate receptors and actually amplifying the strength and frequency of the pulses themselves. When you use them together, these signals reinforce each other and create a surge that's much bigger than either one alone could produce. What makes this pairing special is that ipamorelin is very clean—it triggers growth hormone specifically without flooding your system with other hormones like cortisol or prolactin that could cause unwanted side effects, which is why it's the preferred partner for CJC-1295 over other similar compounds.

Dosage Information

Typical Dose

Ipamorelin: 200-300 mcg + CJC-1295: 100 mcg per dose

Frequency

2-3 times daily, with the most important dose at bedtime

Evening

Administration

Subcutaneous injection, both peptides can be combined in one syringe

Half-Life

2–8 hours

Notes

Administer on empty stomach — avoid food for 30-40 minutes before and after to maximize GH pulse. Bedtime dose aligns with natural nocturnal GH release. Cycles of 3-6 months typically used.

Why this matters

Combined stack where Ipamorelin provides the pulse and CJC-1295 extends duration.

Protocol cycle

3-6 months· Continuous dosing during cycle period

Dose Calculator

Calculate your draw amount for an insulin syringe (U-100)

Concentration: 2,500 mcg/mL

Sign in to save your reconstitution settings for this peptide

Draw to the

8

unit mark

020406080100

Draw 8 units for your 200mcg dose of Ipamorelin + CJC-1295

This calculator is for educational purposes. Always verify your calculations and consult a healthcare professional.

Where does Ipamorelin + CJC-1295 sit?

See how this peptide compares across all 150 peptides in our database.

Evidence Score

0.07

Clinical trials
0.0035%
Literature
0.0030%
Community
0.0020%
Completeness
0.5015%

Potential Side Effects

Water retention initially (common, resolves)Mild fatigue (common in first 1-2 weeks)Tingling in extremities (uncommon)Increased hunger from Ipamorelin (uncommon)Headache (rare)
Pep Talk

Ipamorelin + CJC-1295 discussions

Quick Facts

Administration
Subcutaneous injection, both peptides can be combined in one syringe
Typical Dose
Ipamorelin: 200-300 mcg + CJC-1295: 100 mcg per dose
Frequency
2-3 times daily, with the most important dose at bedtime
References
0 curated + 0 from PubMed
Evidence Score
0.1 / 100

Frequently Asked Questions about Ipamorelin + CJC-1295

What is Ipamorelin + CJC-1295?

The Ipamorelin and CJC-1295 combination is one of the most widely used GH-stimulating peptide protocols in the research and wellness community. Ipamorelin provides a clean selective GHRP effect stimulating GH release without significant cortisol or prolactin elevation while CJC-1295 (with or without DAC) amplifies and extends the GH pulse. Together they produce a synergistic GH release response significantly greater than either compound alone making this one of the most popular stacks for muscle growth recovery fat loss and anti-aging applications.

How does Ipamorelin + CJC-1295 work?

The combination works through complementary pathways in the GH secretion cascade. CJC-1295 binds to GHRH receptors on pituitary somatotrophs priming them to release more GH per pulse and extending the window of GH secretion. Ipamorelin binds to ghrelin receptors (GHSR-1a) amplifying the amplitude of GH pulses and increasing pulsatile frequency. When administered together the two signals converge on pituitary somatotrophs producing a multiplicative rather than simply additive GH release. Ipamorelin's selectivity for GH release without cortisol or prolactin elevation makes it the preferred GHRP partner for CJC-1295 compared to GHRP-6 or GHRP-2 which have more side effects.

What is the recommended dosage for Ipamorelin + CJC-1295?

The typical dose is Ipamorelin: 200-300 mcg + CJC-1295: 100 mcg per dose. 2-3 times daily, with the most important dose at bedtime. Administration: Subcutaneous injection, both peptides can be combined in one syringe. Administer on empty stomach — avoid food for 30-40 minutes before and after to maximize GH pulse. Bedtime dose aligns with natural nocturnal GH release. Cycles of 3-6 months typically used.

What are the side effects of Ipamorelin + CJC-1295?

Water retention initially (common, resolves). Mild fatigue (common in first 1-2 weeks). Tingling in extremities (uncommon). Increased hunger from Ipamorelin (uncommon). Headache (rare)

What is the Ipamorelin + CJC-1295 cycle protocol?

Ipamorelin + CJC-1295 is typically cycled 3-6 months. Continuous dosing during cycle period

Questions reflect common community inquiries. This is not medical advice.